Skip to content

Author

Samuel Robinson

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Integrated Patient-Derived Xenograft and Patient-Derived Cell Models Reveal Therapeutic Vulnerabilities Beyond Standard-of-Care Therapy in Endometrial Cancer

A comprehensive PDX and PDC platform is established as a robust translational resource for preclinical drug evaluation of endometrial cancer and identifies clinically actionable therapeutic advantages, including an epigenetic combination regimen.

Tian-Yue Li, Fang Huang, Xiaohao Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.